Cell Therapeutics (CTIC +0.7%) has regained compliance with Nasdaq's minimum bid price rule. (PR)

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC +0.7%) has regained compliance with Nasdaq's minimum bid price rule. (PR)